Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #42,351 to #42,400.
- DPI-221 (2 revisions)
- DPI-287 (2 revisions)
- DPI-3290 (2 revisions)
- DPM3 (2 revisions)
- DPP6 (2 revisions)
- DPP7 (2 revisions)
- DPP8 (2 revisions)
- DPY19L2 (2 revisions)
- DPYSL3 (2 revisions)
- DRESS syndrome cost-effectiveness of therapy (2 revisions)
- DRESS syndrome future or investigational therapies (2 revisions)
- DRG2 (2 revisions)
- DTL (gene) (2 revisions)
- DTX1 (2 revisions)
- DTX2 (2 revisions)
- DUP17Q12 (2 revisions)
- DURACLON dosage and administration (2 revisions)
- DURACLON dosage forms and strengths (2 revisions)
- DURACLON use in specific populations (2 revisions)
- DUSP16 (2 revisions)
- DUSP2 (2 revisions)
- DUSP22 (2 revisions)
- DUSP4 (2 revisions)
- DVL1 (2 revisions)
- DYNC1I2 (2 revisions)
- DYNC2H1 (2 revisions)
- DYNLL1 (2 revisions)
- DYNLRB1 (2 revisions)
- DYNLT3 (2 revisions)
- DYRK1B (2 revisions)
- Dabigatran (patient information) (2 revisions)
- Dacetuzumab (2 revisions)
- Daclizumab (2 revisions)
- Dacryoadenitis case study one (2 revisions)
- Dacryoadenitis classification (2 revisions)
- Dacryoadenitis cost-effectiveness of therapy (2 revisions)
- Dacryoadenitis differential diagnosis (2 revisions)
- Dacryoadenitis epidemiology and demographics (2 revisions)
- Dacryoadenitis future or investigational therapies (2 revisions)
- Dacryoadenitis historical perspective (2 revisions)
- Dacryoadenitis laboratory findings (2 revisions)
- Dacryoadenitis medical therapy (2 revisions)
- Dacryoadenitis other imaging findings (2 revisions)
- Dacryoadenitis pathophysiology (2 revisions)
- Dacryoadenitis primary prevention (2 revisions)
- Dacryoadenitis risk factors (2 revisions)
- Dacryoadenitis secondary prevention (2 revisions)
- Dacryoadenitis surgery (2 revisions)
- Dactyly (2 revisions)
- Damascenone (2 revisions)